Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors

P. M. Göcze, D. G. Szabó, G. Than, Imre F. Csaha, K. F. Krommer

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The present study was undertaken to test the parallel detectability of ovarian cancer antigen CA 125 and gastrointestinal cancer antigen CA 19-9 in the sera of patients with malignant ovarian tumors, benign ovarian tumors, endometrial cancers, cervical cancers, colorectal cancers, and trophoblastic tumors and in early lst-trimester pregnant as well as in healthy nonpregnant controls. In all kinds of gynecologic and colorectal tumors raised concentrations of both antigens were found with the exception of malignant nonepithclial ovarian tumors where neither of the antigens showed positive reaction. The most positive cases were found in the group with epithelial ovarian cancers. Of the two antigens CA 125 was the more responsive. No positive cases were found with either of the antigens in nonpregnant healthy controls or in patients with benign ovarian tumors. The parallel determination of the two antigens gives us a better opportunity to recognize pelvic tumors and further may enable us to distinguish ovarian and colorectal tumors.

Original languageEnglish
Pages (from-to)268-272
Number of pages5
JournalGynecologic and Obstetric Investigation
Volume25
Issue number4
DOIs
Publication statusPublished - 1988

Fingerprint

CA-19-9 Antigen
Trophoblastic Neoplasms
Neoplasm Antigens
Colorectal Neoplasms
CA-125 Antigen
Serum
Antigens
Neoplasms
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms

Keywords

  • CA 125, ovarian cancer antigen
  • CA 19-9, gastrointestinal cancer antigen
  • Tumors

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors. / Göcze, P. M.; Szabó, D. G.; Than, G.; Csaha, Imre F.; Krommer, K. F.

In: Gynecologic and Obstetric Investigation, Vol. 25, No. 4, 1988, p. 268-272.

Research output: Contribution to journalArticle

@article{783e0e22cfef4da9a9d144624f6c5f05,
title = "Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors",
abstract = "The present study was undertaken to test the parallel detectability of ovarian cancer antigen CA 125 and gastrointestinal cancer antigen CA 19-9 in the sera of patients with malignant ovarian tumors, benign ovarian tumors, endometrial cancers, cervical cancers, colorectal cancers, and trophoblastic tumors and in early lst-trimester pregnant as well as in healthy nonpregnant controls. In all kinds of gynecologic and colorectal tumors raised concentrations of both antigens were found with the exception of malignant nonepithclial ovarian tumors where neither of the antigens showed positive reaction. The most positive cases were found in the group with epithelial ovarian cancers. Of the two antigens CA 125 was the more responsive. No positive cases were found with either of the antigens in nonpregnant healthy controls or in patients with benign ovarian tumors. The parallel determination of the two antigens gives us a better opportunity to recognize pelvic tumors and further may enable us to distinguish ovarian and colorectal tumors.",
keywords = "CA 125, ovarian cancer antigen, CA 19-9, gastrointestinal cancer antigen, Tumors",
author = "G{\"o}cze, {P. M.} and Szab{\'o}, {D. G.} and G. Than and Csaha, {Imre F.} and Krommer, {K. F.}",
year = "1988",
doi = "10.1159/000293797",
language = "English",
volume = "25",
pages = "268--272",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors

AU - Göcze, P. M.

AU - Szabó, D. G.

AU - Than, G.

AU - Csaha, Imre F.

AU - Krommer, K. F.

PY - 1988

Y1 - 1988

N2 - The present study was undertaken to test the parallel detectability of ovarian cancer antigen CA 125 and gastrointestinal cancer antigen CA 19-9 in the sera of patients with malignant ovarian tumors, benign ovarian tumors, endometrial cancers, cervical cancers, colorectal cancers, and trophoblastic tumors and in early lst-trimester pregnant as well as in healthy nonpregnant controls. In all kinds of gynecologic and colorectal tumors raised concentrations of both antigens were found with the exception of malignant nonepithclial ovarian tumors where neither of the antigens showed positive reaction. The most positive cases were found in the group with epithelial ovarian cancers. Of the two antigens CA 125 was the more responsive. No positive cases were found with either of the antigens in nonpregnant healthy controls or in patients with benign ovarian tumors. The parallel determination of the two antigens gives us a better opportunity to recognize pelvic tumors and further may enable us to distinguish ovarian and colorectal tumors.

AB - The present study was undertaken to test the parallel detectability of ovarian cancer antigen CA 125 and gastrointestinal cancer antigen CA 19-9 in the sera of patients with malignant ovarian tumors, benign ovarian tumors, endometrial cancers, cervical cancers, colorectal cancers, and trophoblastic tumors and in early lst-trimester pregnant as well as in healthy nonpregnant controls. In all kinds of gynecologic and colorectal tumors raised concentrations of both antigens were found with the exception of malignant nonepithclial ovarian tumors where neither of the antigens showed positive reaction. The most positive cases were found in the group with epithelial ovarian cancers. Of the two antigens CA 125 was the more responsive. No positive cases were found with either of the antigens in nonpregnant healthy controls or in patients with benign ovarian tumors. The parallel determination of the two antigens gives us a better opportunity to recognize pelvic tumors and further may enable us to distinguish ovarian and colorectal tumors.

KW - CA 125, ovarian cancer antigen

KW - CA 19-9, gastrointestinal cancer antigen

KW - Tumors

UR - http://www.scopus.com/inward/record.url?scp=0023921093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023921093&partnerID=8YFLogxK

U2 - 10.1159/000293797

DO - 10.1159/000293797

M3 - Article

C2 - 2841208

AN - SCOPUS:0023921093

VL - 25

SP - 268

EP - 272

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 4

ER -